Everspin Technologies Azioni (NASDAQ: MRAM)

Ultime notizie per Everspin Technologies (NASDAQ:MRAM) Azioni

Everspin Technologies

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

Everspin Technologies, Inc. - Common Stock

Everspin Technologies Inc

In the current session, Donaldson Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is trading at $61.70, after a 1.66% decrease. Over the past month, the stock decreased by 9.65%, and in the past year, by 14.83%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_0.png" alt="Past Year Chart" />

<h3>Comparing Donaldson P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.15 in the Machinery industry, Donaldson Inc. has a lower P/E ratio of 18.35. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

Price Over Earnings Overview: Donaldson

In the latest quarter, 6 analysts provided ratings for LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $56.17, along with a high estimate of $60.00 and a low estimate of $48.00. Highlighting a 0.28% decrease, the current average has fallen from the previous average price target of $56.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272820_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive LKQ. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $49.00&#x7C;$48.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $48.00&#x7C;$50.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to LKQ. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of LKQ compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of LKQ's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LKQ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on LKQ analyst ratings.</a>
<h2>Delving into LKQ's Background</h2>
Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,500 facilities across North America and Europe. The company primarily sells into the professional channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ typically purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.
<h3>Unraveling the Financial Story of LKQ</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining LKQ's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -4.11% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.65%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): LKQ's ROE stands out, surpassing industry averages. With an impressive ROE of 2.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.03%, the company showcases effective utilization of assets.
Debt Management: LKQ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.93.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

A Glimpse Into The Expert Outlook On LKQ Through 6 Analysts

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 20 years by 1.79% on an annualized basis producing an average annual return of 9.6%. Currently, Carpenter Tech has a market capitalization of $8.37 billion. 
Buying $100 In CRS: If an investor had bought $100 of CRS stock 20 years ago, it would be worth $601.04 today based on a price of $167.60 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745272817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Carpenter Tech 20 Years Ago Would Be Worth Today

Barrington Research analyst Gary Prestopino maintains Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) with a Outperform and maintains $350 price target.

Price Target

Barrington Research Maintains Outperform on Snap-on, Maintains $350 Price Target

Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) has outperformed the market over the past 5 years by 28.78% on an annualized basis producing an average annual return of 41.46%. Currently, Mueller Industries has a market capitalization of $7.58 billion. 
Buying $100 In MLI: If an investor had bought $100 of MLI stock 5 years ago, it would be worth $562.22 today based on a price of $68.45 for MLI at the time of writing.
<h3>Mueller Industries's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745271918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) and Western Alliance Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) shares are trading lower in Monday&#8217;s after-hours session after the pair of regional banks reported financial results<a href="https://www.benzinga.com/pressreleases/25/04/n44910623/zions-bancorporation-national-association-reports-first-quarter-financial-results"> for the first quarter</a>.
Here&#8217;s a look at the headline numbers and key commentary from the reports.
ZION Q1 Earnings: Zions Bancorp reported first-quarter revenue of $795 million, missing analyst estimates of $797.07 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The bank reported first-quarter earnings of $1.13 per share, missing analyst estimates of $1.17 per share.
&#8220;Credit quality remained in very good shape during the quarter, with nonperforming assets stable compared with last quarter at&nbsp;0.51%&nbsp;of loans and leases and annualized net charge-offs of&nbsp;0.11%&nbsp;of loans and leases. At the same time, the&nbsp;outlook&nbsp;for the economy is perhaps more uncertain than it&#8217;s been in a number of years, clouded by the very real potential for negative impacts from tariffs and trade policy, both here and abroad,&#8221; said Harris Simmons, chairman and CEO of Zions Bancorp.
&#8220;We are nevertheless confident that our credit culture and practices and our strong reserves position us to manage through possible turbulence that might materialize in coming quarters.&#8221;
Zions Bancorp shares were down 3.71% after-hours, trading at $42.41 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Zions&#8217; shares are down approximately 20% year-to-date.
WAL Q1 Earnings: Western Alliance reported first-quarter net revenue of $778 million, which appears to have come up short of <a href="https://www.benzinga.com/quote/WAL/earnings">analyst estimates</a>. The bank reported first-quarter earnings of $1.79 per share, beating estimates of $1.78 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
&#8220;Western Alliance delivered solid&nbsp;first quarter&nbsp;results led by continued loan and deposit growth following the completion of our balance sheet repositioning efforts in 2024. Our deep segment and product expertise enables our business to adapt quickly to an evolving macro environment, while our fortified capital and liquidity levels position the firm to maintain business momentum and prudent credit risk management,&#8221; said Kenneth Vecchione, president and CEO of Western Alliance.
Western Alliance shares were moving lower, but faring better than Zions Bancorp shares at last check. The stock was down 1.36% after-hours, trading at $64 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894658/deutsche-bank-standard-chartered-reportedly-looking-into-expanding-to-us-crypto-market">Deutsche Bank, Standard Chartered Reportedly Looking Into Expanding To US Crypto Market</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/etfs/currency-etfs/25/04/44903051/currency-volatility-spikes-as-central-banks-ponder-further-rate-cuts">Currency Volatility Spikes As Central Banks Ponder Further Rate Cuts</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/OLOZANO">OLOZANO</a>/Shutterstock.

Earnings

After-Hours Center

Movers

ZION

Regional Banks Zions, Western Alliance Move Lower Following Q1 Earnings: Key Highlights

Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 1.42% on an annualized basis producing an average annual return of 10.71%. Currently, Globus Medical has a market capitalization of $9.77 billion. 
Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,782.28 today based on a price of $71.01 for GMED at the time of writing.
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745271027_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GMED

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

General

VSME

VS Media Holdings Files For Offering Of Minimum $5M To Maximum $15M Of Class A Shares

PFIS

Peoples Financial Services Files For Mixed Shelf Offering Of Up To $150M

Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) has outperformed the market over the past 5 years by 36.18% on an annualized basis producing an average annual return of 48.86%. Currently, Sprouts Farmers Market has a market capitalization of $15.53 billion. 
Buying $1000 In SFM: If an investor had bought $1000 of SFM stock 5 years ago, it would be worth $7,407.94 today based on a price of $157.50 for SFM at the time of writing.
<h3>Sprouts Farmers Market's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745270110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Sprouts Farmers Market Stock In The Last 5 Years

Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) reported quarterly earnings of $2.69 per share which beat the analyst consensus estimate of $2.49 by 8.03 percent. This is a 6.92 percent decrease over earnings of $2.89 per share from the same period last year.

Earnings Beats

WTFC

Wintrust Finl Q1 EPS $2.69 Beats $2.49 Estimate

Guidance

ATKR

Atkore Sees Q2 2025 Adj. EPS $2.01-$2.08 Vs $1.40 Est.; Revenue $695M-$705M Vs $690.83M Est.; Maintains FY25 Adj. EPS Guidance Of $5.75-$6.85 Vs $6.09 Est.; Revenue $2.85B-$2.95B Vs $2.852B Est

<h3>Gainers</h3>
<ul>
<li>Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) shares rose 23.3% to $0.95 during Monday's after-market session. The company's market cap stands at $6.2 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock rose 8.45% to $0.1. The company's market cap stands at $5.0 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock rose 6.87% to $0.95. The market value of their outstanding shares is at $18.2 million. </li>
<li>Big 5 Sporting Goods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) stock moved upwards by 4.99% to $0.86. The market value of their outstanding shares is at $19.5 million. </li>
<li>Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) stock moved upwards by 4.97% to $1.9. The market value of their outstanding shares is at $68.3 million. </li>
<li>Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) shares rose 4.8% to $33.47. The market value of their outstanding shares is at $176.3 million. The company's, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock declined by 35.5% to $0.25 during Monday's after-market session. The company's market cap stands at $36.0 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) stock fell 17.43% to $0.34. The company's market cap stands at $11.9 million. The company's, Q4 earnings came out 4 days ago. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock decreased by 11.39% to $0.32. The market value of their outstanding shares is at $1.8 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) stock fell 6.85% to $6.94. The market value of their outstanding shares is at $234.2 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares decreased by 5.93% to $2.7. The market value of their outstanding shares is at $3.1 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock fell 5.43% to $0.74. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGFV

DLTH

ECDA

EZGO

FLXS

HOFV

LXEH

MKDW

RYET

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares increased by 23.5% to $1.26 during Monday's after-market session. The company's market cap stands at $17.3 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock increased by 21.05% to $0.28. The company's market cap stands at $24.7 million. </li>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) shares moved upwards by 8.08% to $1.46. The company's market cap stands at $28.4 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares rose 7.65% to $0.23. The company's market cap stands at $1.6 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares increased by 7.63% to $0.72. The market value of their outstanding shares is at $4.7 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares rose 7.03% to $0.24. The company's market cap stands at $1.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares declined by 15.7% to $3.49 during Monday's after-market session. The company's market cap stands at $53.1 million. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares decreased by 11.42% to $0.62. The company's market cap stands at $1.5 million. </li>
<li>Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) stock decreased by 10.04% to $260.0. The market value of their outstanding shares is at $7.9 billion. The company's, Q1 earnings came out today. </li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 9.19% to $5.24. The market value of their outstanding shares is at $7.7 million. </li>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares declined by 7.57% to $1.1. The company's market cap stands at $2.7 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares declined by 6.8% to $0.41. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADIL

ANVS

CLDI

ENVB

MEDP

PRPO

PTIX

SXTC

XAIR

YCBD

ZVSA

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) shares moved upwards by 18.3% to $0.9 during Monday's after-market session. The company's market cap stands at $29.6 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock rose 6.21% to $2.05. The company's market cap stands at $68.5 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock moved upwards by 5.44% to $2.13. The company's market cap stands at $3.2 million. </li>
<li>Wheels Up Experience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) stock increased by 4.98% to $0.82. The company's market cap stands at $572.3 million. </li>
<li>Pangaea Logistics Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANL#NASDAQ">PANL</a>) shares increased by 4.87% to $4.3. The market value of their outstanding shares is at $282.2 million. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares rose 4.83% to $3.25. The market value of their outstanding shares is at $2.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock fell 11.7% to $0.91 during Monday's after-market session. The company's market cap stands at $69.7 million. </li>
<li>Robin Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) shares fell 9.53% to $3.23. </li>
<li>Energy Focus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFOI#NASDAQ">EFOI</a>) stock decreased by 6.56% to $1.71. The company's market cap stands at $8.9 million. </li>
<li>DLH Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) stock fell 5.98% to $3.46. The company's market cap stands at $49.7 million. </li>
<li>Custom Truck One Source (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) stock fell 5.59% to $3.55. The market value of their outstanding shares is at $828.6 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares declined by 5.13% to $0.2. The company's market cap stands at $6.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CTOS

DLHC

EFOI

GPUS

NEOV

OESX

PANL

RBNE

YGMZ

ZCAR

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) stock increased by 17.2% to $4.63 during Monday's after-market session. The company's market cap stands at $754.2 million. </li>
<li>Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) shares rose 13.98% to $37.9. The company's market cap stands at $2.5 billion. As per the press release, Q1 earnings came out today. </li>
<li>Rackspace Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) shares increased by 7.07% to $1.36. The market value of their outstanding shares is at $322.6 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares moved upwards by 6.45% to $0.99. The company's market cap stands at $24.9 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares rose 5.93% to $1.04. The market value of their outstanding shares is at $21.9 million. </li>
<li>Orangekloud Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) stock rose 4.99% to $0.57. The company's market cap stands at $13.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares decreased by 12.8% to $1.3 during Monday's after-market session. The market value of their outstanding shares is at $6.3 million. </li>
<li>Semilux International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELX#NASDAQ">SELX</a>) stock fell 8.15% to $1.24. The market value of their outstanding shares is at $46.4 million. </li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) shares decreased by 7.26% to $0.19. The company's market cap stands at $5.4 million. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) stock fell 6.17% to $1.98. The market value of their outstanding shares is at $14.2 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 6.0% to $11.13. The company's market cap stands at $110.9 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock declined by 5.17% to $2.02. The company's market cap stands at $2.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CALX

FUFU

LEDS

MLGO

ORKT

SELX

SONM

VRAR

12 Information Technology Stocks Moving In Monday's After-Market Session

Medpace Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) reported first-quarter financial results after market close on Monday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/04/b44910790/medpace-holdings-inc-reports-first-quarter-2025-results">from the quarter</a>.
<ul>
<li>Q1 Revenue: $558.57 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $527.15 million</li>
</ul>
<ul>
<li>Q1 EPS: $3.67, versus estimates of $3.06</li>
</ul>
Total revenue was up 9.3% on a year-over-year basis. New business awards totaled $500 million in the quarter, down 18.8% year-over-year. The company ended the period with a backlog of approximately $2.85 billion, down 2.1% year-over-year.
Medpace generated $125.8 million in cash flow from operations during the quarter. The company said it repurchased approximately 1.19 million shares for $389.8 million in the first quarter. Medpace&#8217;s board also authorized a $1 billion increase to the company&#8217;s buyback, bringing the total authorization up to approximately $1.34 billion.
The company ended the quarter with $441.4 million in cash and cash equivalents. 
Outlook: Medpace expects full-year 2025 revenue to be between $2.14 billion and $2.24 billion versus estimates of $2.15 billion. The company anticipates full-year earnings of $12.26 to $13.04 per share versus estimates of $12.27 per share. 
Medpace executives will further discuss the quarter on a call with investors and analysts Tuesday morning at 9 a.m. ET.
MEDP Price Action: <a href="http://benzinga.com/quote/medp">Medpace shares</a> were down 9.34% after-hours, trading at $262 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: • <a href="https://www.benzinga.com/news/buybacks/25/04/44911715/calix-stock-jumps-on-strong-q1-earnings-100-million-buyback-increase">Calix Stock Jumps On Strong Q1 Earnings, $100 Million Buyback Increase</a>
Photo: <a href="https://www.shutterstock.com/g/mariakray">mariakray</a>/Shutterstock.

Biotech

Health Care

Medpace Holdings Reports Q1 Earnings, Shares Move Lower

SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.55 by 21.82 percent. This is a 36.73 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $46.84 million which beat the analyst consensus estimate of $46.23 million by 1.31 percent. This is a 16.79 percent increase over sales of $40.10 million the same period last year.

SMBK

SmartFinancial Q1 Adj $0.67 Beats $0.55 Estimate, Sales $46.84M Beat $46.23M Estimate

Phillips 66 Increases Quarterly Dividend From $1.15 to $1.20

During the last three months, 24 analysts shared their evaluations of Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Nike, revealing an average target of $80.38, a high estimate of $115.00, and a low estimate of $64.00. A 4.45% drop is evident in the current average compared to the previous average price target of $84.12. 
<img src="https://www.benzinga.com/files/images/story/2025/1745269259_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Nike by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;---------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Sam Poser &#x7C;Williams Trading &#x7C;Lowers &#x7C;Buy &#x7C; $73.00&#x7C;$93.00 &#x7C; 
&#x7C;Anna Andreeva &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $70.00&#x7C;$90.00 &#x7C; 
&#x7C;Jim Duffy &#x7C;Stifel &#x7C;Lowers &#x7C;Hold &#x7C; $64.00&#x7C;$75.00 &#x7C; 
&#x7C;Jim Duffy &#x7C;Stifel &#x7C;Maintains &#x7C;Hold &#x7C; $75.00&#x7C;$75.00 &#x7C; 
&#x7C;Alex Straton &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $70.00&#x7C;$72.00 &#x7C; 
&#x7C;Piral Dadhania &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $66.00&#x7C;$67.00 &#x7C; 
&#x7C;Matthew Boss &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $64.00&#x7C;$73.00 &#x7C; 
&#x7C;Jay Sole &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $66.00&#x7C;$73.00 &#x7C; 
&#x7C;Simeon Siegel &#x7C;BMO Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $92.00&#x7C;$95.00 &#x7C; 
&#x7C;Joseph Civello &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $82.00&#x7C;$90.00 &#x7C; 
&#x7C;Ike Boruchow &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $85.00&#x7C;$90.00 &#x7C; 
&#x7C;Jonathan Komp &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $99.00&#x7C;$105.00 &#x7C; 
&#x7C;Cristina Fernandez &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Market Perform &#x7C; $80.00&#x7C;$80.00 &#x7C; 
&#x7C;Tom Nikic &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $75.00&#x7C;$80.00 &#x7C; 
&#x7C;Tom Nikic &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $80.00&#x7C;$84.00 &#x7C; 
&#x7C;Cristina Fernandez &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Market Perform &#x7C; $80.00&#x7C;$80.00 &#x7C; 
&#x7C;Alex Straton &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $72.00&#x7C;$74.00 &#x7C; 
&#x7C;Randal Konik &#x7C;Jefferies &#x7C;Raises &#x7C;Buy &#x7C; $115.00&#x7C;$75.00 &#x7C; 
&#x7C;Cristina Fernandez &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Market Perform &#x7C; $80.00&#x7C;$80.00 &#x7C; 
&#x7C;Robert Drbul &#x7C;Guggenheim &#x7C;Maintains &#x7C;Buy &#x7C; $110.00&#x7C;$110.00 &#x7C; 
&#x7C;Tom Nikic &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $84.00&#x7C;$84.00 &#x7C; 
&#x7C;Paul Lejuez &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $72.00&#x7C;$102.00 &#x7C; 
&#x7C;Cristina Fernandez &#x7C;Telsey Advisory Group&#x7C;Maintains &#x7C;Market Perform &#x7C; $80.00&#x7C;$80.00 &#x7C; 
&#x7C;Simeon Siegel &#x7C;BMO Capital &#x7C;Raises &#x7C;Outperform &#x7C; $95.00&#x7C;$92.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Nike. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Nike compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Nike's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NKE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Nike analyst ratings.</a>
<h2>Get to Know Nike Better</h2>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
<h3>Nike: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Decline in Revenue: Over the 3M period, Nike faced challenges, resulting in a decline of approximately -9.33% in revenue growth as of 28 February, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Nike's net margin is impressive, surpassing industry averages. With a net margin of 7.05%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Nike's ROE excels beyond industry benchmarks, reaching 5.66%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Nike's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.1%, the company showcases efficient use of assets and strong financial health.
Debt Management: Nike's debt-to-equity ratio stands notably higher than the industry average, reaching 0.85. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Nike Stock

Press Releases

Lucid Motors Selects Everspin's PERSYST MRAM for Gravity Electric SUV

Everspin Technologies Announces Date of Third Quarter 2024 Financial Results Conference Call

Everspin Reports Unaudited Third Quarter 2024 Financial Results

Everspin Technologies Appoints William Cooper as Chief Financial Officer

Everspin Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Everspin and Lattice Semiconductor Collaborate to Bring High-Reliability MRAM Solutions to FPGA Platforms

Everspin Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Everspin Awarded $10.5M Contract to Provide MRAM IP and Foundry Services for Purdue University's ME Commons In-Memory Compute Project

Everspin Expands High-Reliability MRAM Portfolio with New Automotive-Grade Offerings

Everspin Announces Date of First Quarter 2025 Financial Results Conference Call

MRAM

Blaize Holdings

Canadian Solar

Datavault AI

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

Kopin

SEALSQ

SemiLEDs

Maxeon Solar Technologies, Ltd. - Ordinary Shares

Maxeon Solar Technologies

Mobix Labs

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Pixelworks

QuickLogic

Semilux International Ltd. - Ordinary Shares

Semilux International

SkyWater Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Everspin Technologies

Notizie

Ultime notizie per Everspin Technologies (NASDAQ:MRAM) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO